SCHEMBL12475650

SCHEMBL12475650

OC(=S)c1sc(-c2ccc(Cl)cc2)nc1C(Br)Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 2/20 0.48
POLB P06746 1/20 0.48
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
ALDH1A1 P00352 5/20 0.44
MAPT P10636 4/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.39
ALOX5 P09917 2/20 0.39
XDH P47989 1/20 0.38
PTGDR2 Q9Y5Y4 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12475734 0.82 SMN1; SMN2 (0.51) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475719 0.81 RAB9A (0.50) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475648 0.81 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475343 0.81 RAB9A (0.65) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475500 0.78 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475559 0.76 MAPT (0.48) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475436 0.75 GAA (0.52) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475304 0.75 NPC1 (0.52) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475713 0.75 TRPM8 (0.70) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL12475339 0.75 MAPT (0.49) RAB9ASMN1; SMN2KDM4ENPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012109573-A1 SUBSTITUTED THIAZOLES FOR USE AS ANTIVIRAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2012-08-16 WO disclosed